mitoxantrone dropped from 2.29 to 1.26 mM and from 6.41 to 2.92 nM (Figure 1b) , and the GI 50 values of SN-38 and doxorubicin dropped from 0.34 to 0.19 mM and from 35.6 to 16.68 nM (Figure 1c) , respectively.
*Corresponding author. Tel: þ31-24-3657514; Fax: þ31-24-3657516; E-mail: j.meis@cwz.nl Sir, Melanized fungi of the order Pleosporales are emerging as causing opportunistic, cutaneous infections in immunocompromised patients mostly resulting from traumatic inoculation of contaminated plant debris. Among the most common aetiological agents of skin disease in the latter disorder are species of the genus Alternaria.
1 Disseminated infection is uncommon but increasing, particularly among severely immunocompromised individuals. 2 Recommendations for therapy are based on case reports and small in vitro studies. New antifungal agents with a better activity may help to improve the management of these infections. We aimed at evaluating the in vitro susceptibility of a collection of Alternaria spp. to amphotericin B, five triazoles and two echinocandins.
A total of 70 strains of Alternaria (CBS Fungal Biodiversity Centre, The Netherlands) consisted of the following isolates: Alternaria infectoria (n¼50), Alternaria alternata (n¼7) and Alternaria malorum (n¼13). Correct identification of isolates was done by sequence analysis of ribosomal DNA. Except for enhancement of sporulation (1 week of incubation at 238C under an alternating light/dark cycle consisting of 8 h of cool-white fluorescent daylight and 16 h of darkness), antifungal susceptibility testing was performed according to CLSI M38-A2. 3 isavuconazole and anidulafungin. Inoculum suspensions were prepared from 7 to 14 day cultures on potato carrot agar, by slightly scraping the surface of mature colonies with a sterile cotton swab wetted with sterile saline including Tween 40 (0.05%). The supernatants were adjusted spectrophotometrically at a wavelength of 530 nm to an optical density (OD) that ranged from 0.25 to 0.3 (2Â10 4 -7Â10 4 cfu/mL). 3 Microdilution plates were incubated at 308C for 48 h (plates with insufficient growth were incubated for 72 h) and read visually after agitation. Table 1 1 Severe deep infections are rare complications and optimal treatment is not known. 2 Various antifungal drugs have been used in the treatment of Alternaria infection, such as amphotericin B, flucytosine, fluconazole, miconazole and nystatin.
1 There are few published data available concerning the in vitro antifungal susceptibility with microdilution techniques of Alternaria species; 4,5 the largest collection included just 13 strains. 4 Reported MIC 50 and MIC 90 values of posaconazole, itraconazole and amphotericin B are comparable to our results. Among the azoles, fluconazole showed uniform low activities against Alternaria species in this and previous studies. 4, 5 Except one report involving 11 isolates, 5 itraconazole, voriconazole and posaconazole had good in vitro activity. Recently, the new azole isavuconazole was tested and generated MIC 50 and MIC 90 values of 1 mg/L. 6 We describe lower in vitro activities (MIC 90 4 mg/L) of voriconazole and isavuconazole. There was no isolate with an MIC of isavuconazole .4 mg/L, suggesting a potential role in therapy and prophylaxis if adequate drug levels are achieved at the site of infection. In contrast, posaconazole demonstrated potent activity (MIC 90 0.25 mg/L) against all clinical and environmental isolates of Alternaria, but it remains to be confirmed that high enough drug levels can be reached at a remote site of infection. Isavuconazole has not been used clinically for Alternaria infections, but posaconazole was the only clinically active antifungal drug in the treatment of a severe invasive Alternaria infection in an immunocompetent patient. 1 In the present study, the antifungal activities of posaconazole and anidulafungin were superior against clinical isolates of A. infectoria. Furthermore, we demonstrated better activity of anidulafungin compared with that of caspofungin, but it is not known whether these in vitro differences are clinically significant. In conclusion, posaconazole and anidulafungin demonstrated the highest in vitro antifungal activity against Alternaria species, including those clinical and environmental isolates that had higher MICs of voriconazole and isavuconazole; their clinical effectiveness in the treatment of Alternaria infection remains to be determined.
